key: cord-0827169-e7cqa5fu authors: Stachel, Anna; Daniel, Kwesi; Ding, Dan; Francois, Fritz; Phillips, Michael; Lighter, Jennifer title: Development and validation of a machine learning model to predict mortality risk in patients with COVID-19 date: 2021-05-07 journal: BMJ Health Care Inform DOI: 10.1136/bmjhci-2020-100235 sha: c32f3d379356c974e277e3e4f0265c44caed76ce doc_id: 827169 cord_uid: e7cqa5fu New York City quickly became an epicentre of the COVID-19 pandemic. An ability to triage patients was needed due to a sudden and massive increase in patients during the COVID-19 pandemic as healthcare providers incurred an exponential increase in workload, which created a strain on the staff and limited resources. Further, methods to better understand and characterise the predictors of morbidity and mortality was needed. METHODS: We developed a prediction model to predict patients at risk for mortality using only laboratory, vital and demographic information readily available in the electronic health record on more than 3395 hospital admissions with COVID-19. Multiple methods were applied, and final model was selected based on performance. A variable importance algorithm was used for interpretability, and understanding of performance and predictors was applied to the best model. We built a model with an area under the receiver operating characteristic curve of 83–97 to identify predictors and patients with high risk of mortality due to COVID-19. Oximetry, respirations, blood urea nitrogen, lymphocyte per cent, calcium, troponin and neutrophil percentage were important features, and key ranges were identified that contributed to a 50% increase in patients’ mortality prediction score. With an increasing negative predictive value starting 0.90 after the second day of admission suggests we might be able to more confidently identify likely survivors DISCUSSION: This study serves as a use case of a machine learning methods with visualisations to aide clinicians with a better understanding of the model and predictors of mortality. CONCLUSION: As we continue to understand COVID-19, computer assisted algorithms might be able to improve the care of patients. ABSTRACT New York City quickly became an epicentre of the COVID- 19 pandemic. An ability to triage patients was needed due to a sudden and massive increase in patients during the COVID-19 pandemic as healthcare providers incurred an exponential increase in workload,which created a strain on the staff and limited resources. Further, methods to better understand and characterise the predictors of morbidity and mortality was needed. Methods We developed a prediction model to predict patients at risk for mortality using only laboratory, vital and demographic information readily available in the electronic health record on more than 3395 hospital admissions with COVID-19. Multiple methods were applied, and final model was selected based on performance. A variable importance algorithm was used for interpretability, and understanding of performance and predictors was applied to the best model. We built a model with an area under the receiver operating characteristic curve of 83-97 to identify predictors and patients with high risk of mortality due to COVID-19. Oximetry, respirations, blood urea nitrogen, lymphocyte per cent, calcium, troponin and neutrophil percentage were important features, and key ranges were identified that contributed to a 50% increase in patients' mortality prediction score. With an increasing negative predictive value starting 0.90 after the second day of admission suggests we might be able to more confidently identify likely survivors Discussion This study serves as a use case of a machine learning methods with visualisations to aide clinicians with a better understanding of the model and predictors of mortality. Conclusion As we continue to understand COVID-19, computer assisted algorithms might be able to improve the care of patients. New York City quickly became an epicentre of the COVID-19 pandemic in the USA. 1 As of 28 April, we identified 7352 cases across our three major medical campuses, of which 3995 were admitted. Due to a sudden and massive increase in patients during COVID-19 pandemic, healthcare providers incurred an exponential increase in workload that created a strain on the staff and limited resources. While mortality prediction models have been developed in patients with septic shock, heart failure and in the intensive care unit, literature does not show a model tailored for patients with COVID-19 in the USA. [2] [3] [4] As COVID-19 is not well characterised, we developed a prediction model using machine learning techniques to identify predictors and patients with high risk of mortality. A prediction model can be used to risk adjust hospitals and unit care, incorporated into an AI notification tool and used in additional studies where a mortality risk score is needed. [5] [6] [7] Hospitals can develop straightforward models with high accuracy to identify predictors that characterise a disease in their patient population. This study adds another prediction model methodology to the literature using primarily objective data readily available electronic health record (EHR) information to classify COVID-19 patient's risk of mortality. This study aims to: (1) develop models to predict daily risk of mortality in hospitalised patients by applying modern machine learning techniques using discrete information found in the EHR and (2) understand and visualise predictors associated with mortality in patients with COVID-19 using variable importance techniques. This study also provides an example how hospitals can leverage their own EHR data to build customised prediction models. Adhering to 'Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis' (TRIPOD) model Open access evaluation, this retrospective cohort study mined structured patient data from the EHR at NYU Langone Health and applied machine learning methods to predict the risk of mortality in patients admitted to the hospital with COVID-19. 8 NYU Langone Health is an academic medical centre located in New York City with over 2000 licenced beds during COVID-19. This study includes patients from three of the medical/surgical campuses comprising of approximately 1700 beds. Data for this study are derived from our Enterprise Data Warehouse-data aggregated from clinical and EPIC clarity tables. The outcome was death during admission in inpatients with COVID-19 confirmed by PCR within prior 60 days of visit. Three datasets with different samplings of the patient population were used to develop three separate models, and a final performance evaluation of the three models was conducted on daily patient mortality predictions to determine the most versatile model (table 1) . All three final 'models included patient demographic information at admission in addition to the following information: (1) laboratory and vital results on the first calendar day of admission-'admission'; (2) last available laboratory and vital results during the admission-'last-value' and (3) laboratory and vital results selected on a random day during the admission-'time-vary'. The training cohorts for all the three datasets included adult inpatients with admitted and subsequently discharged either alive or dead during 3 March 2020-28 April 2020 (n=3395). Patients not admitted or under 18 years of age were excluded. We used the time-holdout method and split hospital admissions into a training dataset (3 March-12 April: n=2054) and an internal validation dataset (13-16 April:, n=477) for internal validation including model tuning and model selection. For the external test set (17-28 April:, n=864), we used future subsequent discharges to test (estimating accuracy of the selected, fully-specified models) and monitor the performance of the models over time. Dividing the data temporally (rather than randomly via cross-validation) for external validation better simulates more realistic results as models trained from historical data will perform similarly in the risk stratification of future patients. A full cohort dataset comprising of 971 patient-level and admission-level features were derived from 83 variables from the EHR (table 1). Features that rely on human decisions such as treatment, or interpretation and documentation such as symptoms and image reviews were excluded to limit the introduction of bias in the model. The cumulative mean, median, min and max of all patients results were calculated along with iterations of the absolute differences among these results at the end of each day until discharge. This engineering allows for laboratory and vital results to be put in the context of the patient rather than the population. For example, low blood pressure might be normal for one patient but unusual for another, and the change in these results during a hospital admission might be indicative of disease progression. Continuous variables were categorised/binned into five groups based on median cutoffs (31, oximetry value <91%, lymphocyte per cent ranging <7, temperature >99.6, calcium ranging 4.1-8.1, mean respirations ranging 23.4-37.2, troponin value 0.09-69.4 and neutrophil percentage ranging 84-99. Conversely, patients with a median-min difference in oximetry value of 0-0.5, respiratory mean-min difference of 0-0.97 or lymphocyte per cent of 24-93 had at least a 20% decrease in their prediction for mortality. This study describes the development of a machine learning model to predict mortality of patients who present and are admitted to the hospital with a confirmed COVID-19 by PCR and provide an accurate daily risk estimate during the patient's stay. The aim of this study was to explore and compare three methods to build a model that could accurately predict risk of death on admission and at each day during the stay of the patient. A strength of the current study was the use over 3000 discharges in a US population. We plan to apply this model to data exported out of clarity each day and provide clinician with daily prediction estimates. The model can be found at Zenodo, along with a sample table that is created prior to applying the model. Unlike other models, it does not require manual calculation of a score, a welcome improvement for the busy clinician. Because the model has high accuracy and is well calibrated, it can be used in other studies as an objective estimation of disease severity. The objective nature of the model is important as it limits biases from documentation issues of overwhelmed clinicians and differences in treatments and provides transparent objective data to characterise severity of a novel disease. Additionally, novel feature engineering methodologies were included such as changes in laboratory/vital Open access results within the context of an individual patient, rather than in the population only, which helped to improve the model's predictions over the course of a patient's stay. Prior studies suggest AI has been slowly gaining traction in healthcare due to the perception that machine learning models are 'black boxes' or not interpretable by the user. 16 The methods demonstrated in this study are more approachable and easily understood by the clinician. This study presented calibration via deciles that is more intuitive for the non-data scientist. Also, a heat map was created to present results from the variable importance algorithm-the distribution of prediction estimates across the binned variables. Users might hesitate to rely on AI for decisions without knowing the risk factors driving the model, despite the computer making accurate recommendations. By providing user's information about the model such as variable importance, the association of each feature level with the outcome provides additional insights serve to facilitate trust that is needed to increase the adoption of AI in the healthcare industry. This model highlights individualised current and prior laboratory and vital results to determine patient-specific mortality risk. Important determinants of risk are further evaluated to illustrate the changes in prediction among patient populations. The interpretability of the model in this study serves to provide insights to intensivists, researchers and administrators of predictors for survivability from a disease with unpredictable or little known outcomes. This retrospective study applied machine learning algorithms to structured patient data from the EHR of a large urban academic health system to create a risk prediction model to predict mortality during admission in patients with confirmed COVID-19. With an AUC of 0.83 at admission, and 0.97 3 days prior to discharge on imputed data, the model discriminates well and is well calibrated. Additionally, the final model's AUC was consistent on both the time held out internal validation and external test sets, which gives more confidence the model will continue to perform well on future data. Because we continue to have large amounts of discharges daily, potential changes in populations and modification of treatment protocols, we plan to continue to monitor performance and retrain model when discrimination falls below 0.8. Ideally, the monitoring of the AUC score should be automated and alert the data scientist when the value falls below a predefined threshold. Hospitals should consider developing their own mortality prediction models based on their specific cohorts, as patient populations may differ across facilities therefore affecting validation results. 17 Finally, and perhaps most importantly, implementation plays a critical role in supporting in the adoption of AI as healthcare systems face increasingly dynamic and resource-constrained conditions. 18 19 While a plethora of literature exists addressing data acquisition, development and validation of models, the application of AI in a real-world healthcare setting has not been substantially addressed. 20 21 22 Often, prediction model results are used to risk adjust and benchmark rates of an outcome. [23] [24] [25] In addition to using prediction estimates as part of a tool, we suggest models be used as tool in the process of understanding and studying a disease. Limitations/next steps The usual limitations associated with an EHR might affect our model. While this model relies on mostly objective data, some inherent bias might be introduced in terms of demographic and laboratory/vital collection and documentation. For example, certain laboratory tests might be ordered on sicker patients or certain types of clinicians might use similar ordering practices that would bias the model. Therefore, the model might be relying on the subjective nature of a clinician rather than purely objective data. On a similar note, patients that might have died after discharge would bias the model. As suggested earlier, results from the model may not be generalisable to other institutions or patient populations; therefore, hospitals should develop tailored models for their own patient population, especially for a disease that is not yet well understood. Because of this, the 'external validation' dataset in this study does not meet the TRIPOD definition as it is using a sample from the same patient population although future population. Furthermore, models need to be continually monitored and retrained when performance degrades. Lastly, this model intends to allocate resources, ensure basic and routine care is completed and quantify the health of a patient. The prediction estimates can be used to create reports adjusting mortality rates by physician, ward or hospital facility. The estimates can also be used to identify high performers to gain insights on potential successful aspects of their care and treatment. The model can be further enhanced by predicting patients who are most likely to unexpectedly expire to gain more insights on how predictors compare with current model. The estimates can also be used for other studies where an objective metric for disease severity is needed. Finally, prediction estimates can be incorporated into an AI tool that can allow clinicians facing a new illness with an uncertain course to identify and prioritise patients who might benefit from targeted, experimental therapy. Hospitals can develop customised prediction models as the amount of EHR data increases, computing power and speeds are faster and machine learning algorithms are broadly accessible. During times of high demand and large uncertainty around a disease, prediction models can help to identify underlying patterns of predictors of disease and be deployed. This study shows how to build a prediction model whereby the predictions improve during the patient's course of stay. Results from a highly accurate model can serve as an objective measure of disease severity where manual review of every cases is not feasible. Similar to other industries, machine learning should be integrated into research and healthcare workflows to better understand and study a disease as well as be incorporated into tools to assist in care, allocate resources and aid in discharge decisions to hopefully save lives. Acknowledgements The authors would like thank to Dr Levi Waldron for his general guidance and mentorship on methodology. Contributors All of the authors were involved in the conception and design of the study, the acquisition of data, the analysis or interpretation of data, and drafting and critical revision of the manuscript for important intellectual content. All approved the final version submitted for publication. AS had full access to the data in the study and takes responsibility for the integrity of the data and accuracy of the data analysis. This study was approved by the NYU Grossman School of Medicine Institutional Review Board (No i20-00671_MOD02), which granted both a waiver of informed consent and a waiver of the Health Information Portability and Privacy Act. Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Competing interests None declared. Patient consent for publication Not required. Provenance and peer review Not commissioned; externally peer reviewed. Data availability statement No data are available. The raw data are not available; however, the model is available at Zenodo (in citation of manuscript). Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise. Open access This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http:// creativecommons. org/ licenses/ by-nc/ 4. 0/. Anna Stachel http:// orcid. org/ 0000-0002-7362-9390 COVID-19: data Derivation and validation of an in-hospital mortality prediction model suitable for profiling Hospital performance in heart failure Real-Time mortality prediction in the intensive care unit A riskmodel for hospital mortality among patients with severe sepsis or septic shock based on German national administrative claims data Coronavirus infections: epidemiological, clinical and immunological features and hypotheses Anomalous Evolution of the Near-Side Jet Peak Shape in Pb-Pb Collisions at sqrt[s_ {NN}]=2.76 TeV Understanding pathways to death in patients with COVID-19 Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration Predictive modeling of the hospital readmission risk from patients' claims data using machine learning: a case study on Graphical assessment of internal and external calibration of logistic regression models by using Loess smoothers Assessing the performance of prediction models: a framework for traditional and novel measures Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data A unified approach to interpreting model predictions Development and validation of a machine learning prediction model as part of an AI notification tool to predict mortality risk in patients with COVID Predictive learning via rule ensembles Storm Evader: using an iPad to teach kids about Meteorology and technology External validation of new risk prediction models is infrequent and reveals worse prognostic discrimination What is dissemination and implementation science?: an introduction and opportunities to advance behavioral medicine and public health globally An introduction to implementation science for the non-specialist Implementing electronic health care predictive analytics: considerations and challenges The skilled nursing facility value-based purchasing program (snf VBP) Risk prediction models for hospital readmission: a systematic review Update of the trauma risk adjustment model of the TraumaRegister DGU™: the revised injury severity classification, version II Development of a risk adjustment mortality model using the American College of Cardiology-National cardiovascular data registry (ACC-NCDR) experience: 1998-2000 Enhancement of claims data to improve risk adjustment of hospital mortality